These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 29196917)
1. Development of a linear dual column HPLC-MS/MS method and clinical genetic evaluation for tramadol and its phase I and II metabolites in oral fluid. Yu H; Hong S; Jeong CH; Bae JW; Lee S Arch Pharm Res; 2018 Mar; 41(3):288-298. PubMed ID: 29196917 [TBL] [Abstract][Full Text] [Related]
2. Development of a column-switching LC-MS/MS method of tramadol and its metabolites in hair and application to a pharmacogenetic study. Yu H; Choi M; Jang JH; Park B; Seo YH; Jeong CH; Bae JW; Lee S Arch Pharm Res; 2018 May; 41(5):554-563. PubMed ID: 29524157 [TBL] [Abstract][Full Text] [Related]
3. Tramadol chronic abuse: an evidence from hair analysis by LC tandem MS. Verri P; Rustichelli C; Palazzoli F; Vandelli D; Marchesi F; Ferrari A; Licata M J Pharm Biomed Anal; 2015 Jan; 102():450-8. PubMed ID: 25459945 [TBL] [Abstract][Full Text] [Related]
4. Development and validation of an HPLC-UV method for simultaneous determination of sildenafil and tramadol in biological fluids: Application to drug-drug interaction study. Dahshan HE; Helal MA; Mostafa SM; Elgawish MS J Pharm Biomed Anal; 2019 May; 168():201-208. PubMed ID: 30825803 [TBL] [Abstract][Full Text] [Related]
5. Quantitation of the enantiomers of tramadol and its three main metabolites in human whole blood using LC-MS/MS. Haage P; Kronstrand R; Carlsson B; Kugelberg FC; Josefsson M J Pharm Biomed Anal; 2016 Feb; 119():1-9. PubMed ID: 26625281 [TBL] [Abstract][Full Text] [Related]
6. Concentrations of tramadol and O-desmethyltramadol enantiomers in different CYP2D6 genotypes. Stamer UM; Musshoff F; Kobilay M; Madea B; Hoeft A; Stuber F Clin Pharmacol Ther; 2007 Jul; 82(1):41-7. PubMed ID: 17361124 [TBL] [Abstract][Full Text] [Related]
7. Population pharmacokinetic analysis of tramadol and Lee J; Yoo HD; Bae JW; Lee S; Shin KH Drug Des Devel Ther; 2019; 13():1751-1761. PubMed ID: 31213765 [No Abstract] [Full Text] [Related]
8. Temporal patterns of tramadol in hair after a single dose. Johansen SS; Dang LTVL; Nielsen MKK; Haage P; Kugelberg FC; Kronstrand R Forensic Sci Int; 2020 Nov; 316():110546. PubMed ID: 33142187 [TBL] [Abstract][Full Text] [Related]
9. Role of hair pigmentation in drug incorporation into hair. Yu H; Jang WJ; Jang JH; Park B; Seo YH; Jeong CH; Lee S Forensic Sci Int; 2017 Dec; 281():171-175. PubMed ID: 29156328 [TBL] [Abstract][Full Text] [Related]
10. Impact of CYP genotype and inflammatory markers on the plasma concentrations of tramadol and its demethylated metabolites and drug tolerability in cancer patients. Tanaka H; Naito T; Sato H; Hiraide T; Yamada Y; Kawakami J Eur J Clin Pharmacol; 2018 Nov; 74(11):1461-1469. PubMed ID: 30051214 [TBL] [Abstract][Full Text] [Related]
11. Enantioselective pharmacokinetics of tramadol and its three main metabolites; impact of Haage P; Kronstrand R; Josefsson M; Calistri S; van Schaik RHN; Green H; Kugelberg FC Pharmacol Res Perspect; 2018 Jul; 6(4):e00419. PubMed ID: 29992026 [TBL] [Abstract][Full Text] [Related]
13. CYP2D6 polymorphism in relation to tramadol metabolism: a study of faroese patients. Halling J; Weihe P; Brosen K Ther Drug Monit; 2008 Jun; 30(3):271-5. PubMed ID: 18520597 [TBL] [Abstract][Full Text] [Related]
14. Influence of Obesity and Type 2 Diabetes Mellitus on the Pharmacokinetics of Tramadol After Single Oral Dose Administration. Porażka J; Szałek E; Połom W; Czajkowski M; Grabowski T; Matuszewski M; Grześkowiak E Eur J Drug Metab Pharmacokinet; 2019 Aug; 44(4):579-584. PubMed ID: 30778911 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of tramadol enantiomers and their respective phase I metabolites in relation to CYP2D6 phenotype. García-Quetglas E; Azanza JR; Sádaba B; Muñoz MJ; Gil I; Campanero MA Pharmacol Res; 2007 Feb; 55(2):122-30. PubMed ID: 17175164 [TBL] [Abstract][Full Text] [Related]
16. Effects of terbinafine and itraconazole on the pharmacokinetics of orally administered tramadol. Saarikoski T; Saari TI; Hagelberg NM; Backman JT; Neuvonen PJ; Scheinin M; Olkkola KT; Laine K Eur J Clin Pharmacol; 2015 Mar; 71(3):321-7. PubMed ID: 25560051 [TBL] [Abstract][Full Text] [Related]
17. Post-mortem SNP analysis of CYP2D6 gene reveals correlation between genotype and opioid drug (tramadol) metabolite ratios in blood. Levo A; Koski A; Ojanperä I; Vuori E; Sajantila A Forensic Sci Int; 2003 Jul; 135(1):9-15. PubMed ID: 12893130 [TBL] [Abstract][Full Text] [Related]
18. Effect of the cytochrome P450 2D6*10 genotype on the pharmacokinetics of tramadol in post-operative patients. Xu J; Zhang XC; Lv XQ; Xu YY; Wang GX; Jiang B; Cai L; Cai XJ Pharmazie; 2014 Feb; 69(2):138-41. PubMed ID: 24640604 [TBL] [Abstract][Full Text] [Related]
19. Pharmacogenetic aspects of tramadol pharmacokinetics and pharmacodynamics after a single oral dose. Bastami S; Haage P; Kronstrand R; Kugelberg FC; Zackrisson AL; Uppugunduri S Forensic Sci Int; 2014 May; 238():125-32. PubMed ID: 24709712 [TBL] [Abstract][Full Text] [Related]
20. The Associations Between CYP2D6*10 C188T Polymorphism and Pharmacokinetics and Clinical Outcomes of Tramadol: A Systematic Review and Meta-analysis. Wen QH; Zhang Z; Cai WK; Lin XQ; He GH Pain Med; 2020 Dec; 21(12):3679-3690. PubMed ID: 32488232 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]